Active Ingredient: CEFAZOLIN SODIUM
Proprietary Name: CEFAZOLIN SODIUM
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 2GM BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N216109
Product Number: 001
Approval Date: Oct 7, 2022
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information